Cargando…
The effect of deadlines on cancer screening completion: a randomized controlled trial
Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field e...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260724/ https://www.ncbi.nlm.nih.gov/pubmed/34230556 http://dx.doi.org/10.1038/s41598-021-93334-1 |
_version_ | 1783718866585649152 |
---|---|
author | Lieberman, Alicea Gneezy, Ayelet Berry, Emily Miller, Stacie Koch, Mark Argenbright, Keith E. Gupta, Samir |
author_facet | Lieberman, Alicea Gneezy, Ayelet Berry, Emily Miller, Stacie Koch, Mark Argenbright, Keith E. Gupta, Samir |
author_sort | Lieberman, Alicea |
collection | PubMed |
description | Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field experiment (n = 7711), we tested whether deadlines—both with and without monetary incentives tied to them—increase colorectal cancer (CRC) screening. We found that all screening invitations with an imposed deadline increased completion, ranging from 2.5% to 7.3% relative to control (ps < .004). Most importantly, individuals who received a short deadline with no incentive were as likely to complete screening (9.7%) as those whose invitation included a deadline coupled with either a small (9.1%) or large declining financial incentive (12.0%; ps = .57 and .04, respectively). These results suggest that merely imposing deadlines—especially short ones—can significantly increase CRC screening completion, and may also have implications for other forms of cancer screening. |
format | Online Article Text |
id | pubmed-8260724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82607242021-07-08 The effect of deadlines on cancer screening completion: a randomized controlled trial Lieberman, Alicea Gneezy, Ayelet Berry, Emily Miller, Stacie Koch, Mark Argenbright, Keith E. Gupta, Samir Sci Rep Article Cancer is the second leading cause of death in the United States. Although screening facilitates prevention and early detection and is one of the most effective approaches to reducing cancer mortality, participation is low—particularly among underserved populations. In a large, preregistered field experiment (n = 7711), we tested whether deadlines—both with and without monetary incentives tied to them—increase colorectal cancer (CRC) screening. We found that all screening invitations with an imposed deadline increased completion, ranging from 2.5% to 7.3% relative to control (ps < .004). Most importantly, individuals who received a short deadline with no incentive were as likely to complete screening (9.7%) as those whose invitation included a deadline coupled with either a small (9.1%) or large declining financial incentive (12.0%; ps = .57 and .04, respectively). These results suggest that merely imposing deadlines—especially short ones—can significantly increase CRC screening completion, and may also have implications for other forms of cancer screening. Nature Publishing Group UK 2021-07-06 /pmc/articles/PMC8260724/ /pubmed/34230556 http://dx.doi.org/10.1038/s41598-021-93334-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lieberman, Alicea Gneezy, Ayelet Berry, Emily Miller, Stacie Koch, Mark Argenbright, Keith E. Gupta, Samir The effect of deadlines on cancer screening completion: a randomized controlled trial |
title | The effect of deadlines on cancer screening completion: a randomized controlled trial |
title_full | The effect of deadlines on cancer screening completion: a randomized controlled trial |
title_fullStr | The effect of deadlines on cancer screening completion: a randomized controlled trial |
title_full_unstemmed | The effect of deadlines on cancer screening completion: a randomized controlled trial |
title_short | The effect of deadlines on cancer screening completion: a randomized controlled trial |
title_sort | effect of deadlines on cancer screening completion: a randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260724/ https://www.ncbi.nlm.nih.gov/pubmed/34230556 http://dx.doi.org/10.1038/s41598-021-93334-1 |
work_keys_str_mv | AT liebermanalicea theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT gneezyayelet theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT berryemily theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT millerstacie theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT kochmark theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT argenbrightkeithe theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT guptasamir theeffectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT liebermanalicea effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT gneezyayelet effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT berryemily effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT millerstacie effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT kochmark effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT argenbrightkeithe effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial AT guptasamir effectofdeadlinesoncancerscreeningcompletionarandomizedcontrolledtrial |